Show source-provided references
2. Shimamura, S.S., Shukuya, T., Asao, T., Hayakawa, D., Kurokawa, K., Xu, S., Miura, K., Mitsuishi, Y., Tajima, K., and Shibayama, R. (2022). Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer—Is there a “tail plateau” in the survival curve of these patients?. BMC Cancer, 22.
10.1186/s12885-022-09421-7 ↗4. Change in survival in metastatic breast cancer with treatment advances: Meta-analysis and systematic review
10.1093/jncics/pky062 ↗6. Khatoon, E., Banik, K., Harsha, C., Sailo, B.L., Thakur, K.K., Khwairakpam, A.D., Vikkurthi, R., Devi, T.B., Gupta, S.C., and Kunnumakkara, A.B. (2020). Seminars in Cancer Biology, Elsevier.
7. Sanati, M., Afshari, A.R., Ahmadi, S.S., Moallem, S.A., and Sahebkar, A. (BioFactors, 2023). Modulation of the ubiquitin-proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors, BioFactors, early view.
10.1002/biof.1958 ↗10. Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence
10.1002/ptr.7350 ↗13. The protective role of curcumin in myocardial ischemia–reperfusion injury
17. Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer
10.1002/jcp.26538 ↗21. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years
10.4103/jcrt.JCRT_1017_20 ↗25. Shakibaei, M., Buhrmann, C., Kraehe, P., Shayan, P., Lueders, C., and Goel, A. (2014). Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures. PLoS ONE, 9.
10.1371/journal.pone.0085397 ↗26. Shakibaei, M., Mobasheri, A., Lueders, C., Busch, F., Shayan, P., and Goel, A. (2013). Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PLoS ONE, 8.
10.1371/journal.pone.0057218 ↗27. Shakibaei, M., Kraehe, P., Popper, B., Shayan, P., Goel, A., and Buhrmann, C. (2015). Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer. BMC Cancer, 15.
10.1186/s12885-015-1291-0 ↗28. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice
10.1186/s13046-017-0661-7 ↗29. Curcumin analog pentagamavunon-1 (PGV-1) sensitizes Widr cells to 5-fluorouracil through inhibition of NF-κB activation
31. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer
10.1093/carcin/bgv006 ↗32. Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress
10.1016/j.biopha.2020.110381 ↗33. Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway
10.2147/OTT.S199601 ↗34. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment
10.1016/j.bbagen.2014.06.004 ↗35. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N, O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies
10.1016/j.ejpb.2014.04.017 ↗36. Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells
10.1016/j.pharep.2017.10.004 ↗37. Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX
10.1593/tlo.09193 ↗38. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R
39. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
10.1016/j.canlet.2015.05.005 ↗40. Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa trial
10.1093/jn/nxz029 ↗41. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil
10.1038/cddis.2013.26 ↗42. Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma
10.2147/IJN.S108633 ↗43. Curcumin and paclitaxel induce cell death in breast cancer cell lines
44. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma
10.1088/1361-6528/ab6d20 ↗45. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation
10.1016/j.colsurfb.2019.110515 ↗46. Co-delivery of doxorubicin and curcumin to breast cancer cells by a targeted delivery system based on Ni/Ta core-shell metal-organic framework coated with folic acid-activated chitosan nanoparticles
10.1007/s13738-022-02604-w ↗48. Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer
49. The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: A pilot phase II study
10.1159/000441148 ↗50. Curcumin Upregulates miR-148a to Increase the Chemosensitivity of CD44-Positive Prostate Cancer Stem Cells to Paclitaxel Through Targeting the MSK1/IRS1 axis
10.1055/a-1867-4805 ↗51. Combination of curcumin and metformin inhibits cell growth and induces apoptosis without affecting the cell cycle in LNCaP prostate cancer cell line
10.1080/01635581.2020.1783327 ↗52. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles
10.1016/j.biopha.2020.110181 ↗55. Curcumin enhances the anticancer effect of 5-fluorouracil against gastric cancer through down-regulation of COX-2 and NF-κB signaling pathways
10.7150/jca.20196 ↗56. Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells
58. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells
59. Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma
10.1002/jbt.22486 ↗60. Combined effects of curcumin and doxorubicin on cell death and cell migration of SH-SY5Y human neuroblastoma cells
10.1007/s11626-018-0288-9 ↗61. Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death
10.1186/s13046-019-1234-8 ↗63. Curcumin enhances cisplatin-induced human laryngeal squamous cancer cell death through activation of TRPM2 channel and mitochondrial oxidative stress
10.1038/s41598-019-54284-x ↗64. The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol
65. Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin-resistant oral cancer CAR cells through intrinsic apoptotic process
67. mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy
10.1038/s41388-018-0345-6 ↗68. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers
10.1016/j.colsurfb.2018.03.046 ↗72. Multidrug resistance affects the prognosis of primary epithelial ovarian cancer
74. Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells
10.3892/ol.2016.5192 ↗75. Co-delivery of curcumin and paclitaxel by “core-shell” targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer
10.2147/IJN.S224579 ↗76. Duse, L., Agel, M.R., Pinnapireddy, S.R., Schäfer, J., Selo, M.A., Ehrhardt, C., and Bakowsky, U. (2019). Photodynamic therapy of ovarian carcinoma cells with curcumin-loaded biodegradable polymeric nanoparticles. Pharmaceutics, 11.
10.3390/pharmaceutics11060282 ↗77. Curcumin-loaded PEGylated mesoporous silica nanoparticles for effective photodynamic therapy
10.1039/D0RA04778C ↗78. PEGylated lipid nanocarrier for enhancing photodynamic therapy of skin carcinoma using curcumin: In-vitro/in-vivo studies and histopathological examination
10.1038/s41598-020-67349-z ↗80. Self-delivered and self-monitored chemo-photodynamic nanoparticles with light-triggered synergistic antitumor therapies by downregulation of HIF-1α and depletion of GSH
10.1021/acsami.9b23325 ↗81. Busa, P., Kankala, R.K., Deng, J.-P., Liu, C.-L., and Lee, C.-H. (2022). Conquering cancer multi-drug resistance using curcumin and cisplatin prodrug-encapsulated mesoporous silica nanoparticles for synergistic chemo-and photodynamic therapies. Nanomaterials, 12.
10.3390/nano12203693 ↗83. Gadolinium-doped hollow silica nanospheres loaded with curcumin for magnetic resonance imaging-guided synergistic cancer sonodynamic-chemotherapy
10.1016/j.msec.2021.112157 ↗84. Multiplex fluorescence imaging-guided programmed delivery of doxorubicin and curcumin from a nanoparticles/hydrogel system for synergistic chemotherapy
10.1002/pol.20210600 ↗88. Mukherjee, S., Baidoo, J.N., Sampat, S., Mancuso, A., David, L., Cohen, L.S., Zhou, S., and Banerjee, P. (2018). Liposomal TriCurin, a synergistic combination of curcumin, epicatechin gallate and resveratrol, repolarizes tumor-associated microglia/macrophages, and eliminates glioblastoma (GBM) and GBM stem cells. Molecules, 23.
10.3390/molecules23010201 ↗90. A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer
10.1038/s41598-018-32267-8 ↗91. Curcumin-and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on HCT116 colorectal cancer model
10.3389/fbioe.2020.00050 ↗92. Pro-apoptotic genes as new targets for single and combinatorial treatments with resveratrol and curcumin in colorectal cancer
10.1039/C9FO01014A ↗93. Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines
10.1002/jcp.27761 ↗95. Gallic acid and curcumin induce cytotoxicity and apoptosis in human breast cancer cell MDA-MB-231
10.15171/bi.2018.21 ↗96. Efficient synergistic combination effect of Quercetin with Curcumin on breast cancer cell apoptosis through their loading into Apo ferritin cavity
10.1016/j.colsurfb.2020.110982 ↗97. Synergistic antiproliferative effects of co-nanoencapsulated curcumin and chrysin on mda-mb-231 breast cancer cells through upregulating mir-132 and mir-502c
10.1080/01635581.2019.1599968 ↗98. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells
10.1016/j.phymed.2018.09.224 ↗100. Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway
10.1177/09603271221095929 ↗